MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Clinical and radiological factors associated with mortality in Parkinson’s disease

    G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, R. Luquin (Pamplona, Spain)

    Objective: To assess clinical and radiological risk factors of mortality in a cohort of patients with a clinical diagnosis of Parkinson’s disease (PD) according to…
  • 2023 International Congress

    Polyneuropathy in Parkinson’s disease: cross-sectional analysis of the Bochum Parkinson Nerve Study cohort

    R. Scherbaum, L. Basner, L. Ortmann, J. Steininger, K. Müller, A. Bieber, P. Schülken, J. Motte, A. Fisse, T. Grüter, R. Gold, K. Pitarokoili, L. Tönges (Bochum, Germany)

    Objective: To describe the prevalence of large-fiber polyneuropathy (PNP) in people with PD and examine differences between subjects with or without PNP. Background: Non-motor symptoms…
  • 2023 International Congress

    Retrospective exploration of the 5-2-1 criteria in clinical practice

    M. Karlstedt, A. Johansson (Stockholm, Sweden)

    Objective: To explore documentation in medical records (EMRs) of the 5 (5 oral levodopa doses taken/day) -2 (2hours of OFF time/day) -1 (1 hour of…
  • 2023 International Congress

    Axial impairment and bradykinesia are related to increased CSF sTREM2, a neuroinflammation biomarker, in Parkinson’s disease

    A. Brück, R. Ajalin, H. Al-Abdulrasul, H. Zetterberg, K. Blennow, E. Löyttyniemi, J. Rinne (Turku, Finland)

    Objective: To explore the association between Parkinson’s disease (PD) motor symptoms and CSF biomarkers for neuroinflammation and neurodegeneration. Background: Previous in vivo and post mortem…
  • 2023 International Congress

    The examination of the relationship between limited thoracic mobility and shoulder joint function in individuals with extrapyramidal syndrome

    C. Bouzineki, A. Christakou, S. Kanellopoulou, X. Arabatzi, V. Sakellari (Athens, Greece)

    Objective: To explore the effect of limited thoracic mobility on shoulder joint functionality in extrapyramidal patients over 60 years of age. Background: The extrapyramidal motor…
  • 2023 International Congress

    Safety assessment of pimavanserin in Parkinson’s disease psychosis patients: Evidence from a systematic review and meta-analysis of randomized controlled trials

    G. Bano, A. Sharma (New Delhi, India)

    Objective: This systematic review and meta-analysis aimed to assess the safety profile of pimavanserin in Parkinson’s disease psychosis (PDP) patients from the available randomized controlled…
  • 2023 International Congress

    Exome sequencing of 584 Chinese proband with brain calcification

    ZR. Lin (Hangzhou, China)

    Objective: The aim of this study is to evaluate the diagnostic value of whole exome sequencing in Chinese patients with brain calcification, and to provide exome sequencing-based insights into the genetic…
  • 2023 International Congress

    Evoked resonant neural activity in Globus Pallidus vs. Subthalamic Nucleus of patients with Parkinson’s Disease, preliminary results

    L. Branco, C. Swamy, A. Tarakad, N. Vanegas-Arroyave, I. Patel, N. Ince, A. Viswanathan (Houston, USA)

    Objective: Compare the evoked resonant neural activity (ERNA) responses obtained from stimulation of Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) in patients with Parkinson’s…
  • 2023 International Congress

    Neuropathic mechanism of paroxysmal kinesigenic dyskinesia based on EEG

    XJ. Huang, HC. Luo, TF. Yuan, L. Cao (Shanghai, China)

    Objective: To disclose the neural mechanism of paroxysmal kinesigenic dyskinesia (PKD) based on the findings from high-density electroencephalogram (hd-EEG) and to explore a neural biomarker for…
  • 2023 International Congress

    Utility of quantitative EEG during sleep as a potential biomarker of Lewy body disease progression

    E. Matar, K. Ehgoetz Martens, R. Grunstein, A. D'Rozario, S. Lewis (Sydney, Australia)

    Objective: Objective: To assess whether progression from isolated REM sleep behaviour disorder (iRBD), established Parkinson’s disease (PD) and Dementia with Lewy bodies (DLB) are accompanied…
  • « Previous Page
  • 1
  • …
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley